Glycodin is a cough syrup launched in 1930 by Alembic Pharmaceuticals. It was switched from prescription to over-the-counter in 2002. While it was a Rs. 10 crore brand in 2000, it now faces competition from other cough syrups. The product formulation was changed in 2015 when codeine was replaced. It is marketed for cough, cold, and respiratory infections, and sold for Rs. 60 for 50 ml and Rs. 91.60 for 100ml primarily through chemists and doctors with some advertisement and promotion. Lack of consumer awareness and promotional activities are identified as key issues.